Research library / Metformin

CC Small or few human trials. Promising, not proven. How we grade →Retrospective cohort and twin study · Danish national registers, singletons and discordant twin pairs

Reassessing the evidence of a survival advantage in Type 2 diabetes treated with metformin compared with controls without diabetes: a retrospective cohort study

M Keys, M Thinggaard, L Larsen, D Pedersen, J Hallas, K Christensen. International Journal of Epidemiology. 2022.

Published Sources checked 1 sourceEverstack research teamHow we work

In plain language
In Danish registers, people with type 2 diabetes starting metformin had higher mortality than people without diabetes (adjusted rate ratio 1.32; 1.64 in twin pairs), so the earlier survival advantage was not reproduced.
Limits
Observational; one country.
Which of our grades it feeds
Source
doi.org/10.1093/ije/dyac200 · PubMed 36287641

Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.